ArticleOncology letters2026

Efficacy and safety of blinatumomab combination therapy in high-risk B-cell acute lymphoblastic leukemia: A systematic review and meta-analysis.

Mei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.